Analysis of prodromal symptoms and need for short-term prophylaxis in angioedema patients under long-term prophylaxis
Abstract Background Patients with hereditary angioedema (HAE) experience recurrent, unpredictable episodes of edema. These swellings are often preceded by prodromal symptoms. HAE management includes acute treatment, long-term prophylaxis (LTP), and short-term prophylaxis (STP) before procedures with...
Saved in:
| Main Authors: | Robin Lochbaum, Thomas K. Hoffmann, Jens Greve, Janina Hahn |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | Orphanet Journal of Rare Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13023-025-03562-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolution of Treatments for Hereditary Angioedema in Italy: Use of Lanadelumab in Clinical Practice
by: Marta Nugnes, et al.
Published: (2025-06-01) -
A single-centre retrospective study on the clinical characteristics of patients with hereditary angioedema and the therapeutic effect of lanadelumab
by: Yanhua Xu, et al.
Published: (2025-08-01) -
One-year real-life outcomes of lanadelumab therapy in Romanian patients with hereditary angioedema due to C1-inhibitor deficiency
by: Noémi Anna Bara, et al.
Published: (2025-08-01) -
Hereditary angioedema plasma proteomics following specific plasma kallikrein inhibition with lanadelumab
by: Dan Sexton, et al.
Published: (2025-05-01) -
The latest therapeutic reports on short-term and long-term prophylaxis in the treatment of hereditary angioedema
by: Maciej Kozłowski, et al.
Published: (2024-02-01)